Makers Laboratories

Makers Laboratories Inventory

The Inventory of Makers Laboratories (506919.BO) as of Oct 25, 2026 is 449.41 M INR. In the previous year, Inventory was 340.37 M INR — a change of 32.04% (higher).

Inventory

449.41 MINR

YoY

32.04%

Last updated:

Inventory of Makers Laboratories is 2026 449.41 M INR. Inventory of Makers Laboratories was 2025 340.37 M INR. It decreases by 32.04% higher compared to the previous year.

The Makers Laboratories Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
119.36 M INR
Jan 1, 2020
111.02 M INR
Jan 1, 2021
277.64 M INR
Jan 1, 2022
267.28 M INR
Jan 1, 2023
319.12 M INR
Jan 1, 2024
338.05 M INR
Jan 1, 2025
340.37 M INR
Jan 1, 2026
449.41 M INR
The Makers Laboratories Inventory history
YEARInventoryYoY
449.41 MINR+32.04%
340.37 MINR+0.69%
338.05 MINR+5.93%
319.12 MINR+19.39%
267.28 MINR-3.73%
277.64 MINR+150.08%
111.02 MINR-6.99%
119.36 MINR-10.56%
133.46 MINR+66.98%
79.92 MINR+30.88%
61.07 MINR-33.97%
92.49 MINR-6.76%
99.19 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical products across various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). These brands target general health needs and are distributed through the Inspira retail packs division, which covers categories like acid regulatory, anthelmintics, anti-allergics, and anti-hypertensives. The Experia bulk packs division supplies bulk pharmaceutical products including amoxycillin 250 mg capsules and chloroquine phosphate 250 mg tablets to healthcare providers and pharmacies. The company's primary customers are healthcare providers and pharmacies that purchase its formulation brands and bulk packs for resale or direct patient use. The Inspira retail packs division serves retail consumers seeking over-the-counter medications for common ailments, while the Experia bulk packs division caters to institutional buyers needing bulk quantities for distribution. Makers Laboratories Ltd. focuses on the pharmaceuticals segment, offering products that address diverse health conditions through its established brand portfolio. Revenue streams are derived from both retail and bulk sales, with formulation brands driving consumer-facing sales and bulk packs supporting institutional distribution. The company's product range spans multiple therapeutic areas, ensuring consistent demand across different healthcare segments. By maintaining a diverse portfolio of branded and bulk pharmaceutical products, Makers Laboratories Ltd. effectively targets both end consumers and healthcare institutions within the Indian pharmaceutical market. Makers Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Makers Laboratories stock

Inventory of Makers Laboratories is 449.41 M INR in 2026.

Inventory of Makers Laboratories changed from 340.37 M INR to 449.41 M INR, representing a 32.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Makers Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Makers Laboratories

All Key Metrics — Makers Laboratories